Incannex Healthcare (ASX: IHL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Incannex Healthcare Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Incannex Healthcare (ASX: IHL)
Latest News
Cannabis Shares
These were the best performing ASX cannabis shares in October
Share Gainers
Incannex (ASX:IHL) share price leaps 6% on manufacturing update
Healthcare Shares
How did ASX healthcare shares perform in the FY22 first quarter?
Healthcare Shares
The Incannex (ASX:IHL) share price has lost 20% in 4 weeks. What's happening?
Share Market News
What's going wrong for ASX cannabis shares lately?
Share Gainers
The Incannex (ASX:IHL) share price is up 40% in a month. Here's why
Cannabis Shares
Why the Incannex (ASX:IHL) share price is rocketing 170% in 2021
Share Gainers
Why the Incannex (ASX:IHL) share price leapt 9% today
Cannabis Shares
Incannex (ASX:IHL) share price flat after earnings report
Share Market News
Incannex (ASX:IHL) share price up on patent application announcement
Share Market News
Here's why Incannex (ASX:IHL) shares are in a trading halt
Share Market News
Incannex (ASX:IHL) share price backtracks on FDA update
Frequently Asked Questions
-
Incannex listed on the ASX in May 2007.
-
No, Incannex has not yet paid out any dividends.
IHL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Incannex Healthcare
Incannex Healthcare Ltd (ASX: IHL) is a developer of cannabinoid and psychedelic compound medicines. It is currently involved in clinical programs for the treatment of six conditions: Obstructive Sleep Apnea (OSA), Generalised Anxiety Disorder (GAD), traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions.
The company has an Australian license to import, export, and distribute medicinal cannabis products and has a line of cannabinoid products.